Complete Filing Data
Park Ha Biological Technology Co., Ltd. reported Stockholders Equity of $3.99 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Park Ha Biological Technology Co., Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Selling And Marketing Expense | $625.3K | $361.3K | $299.6K | $438.6K |
| Revenues | $2.5M | $2.4M | $2.5M | $1.9M |
| Research And Development Expense | $238.2K | $36.7K | $30.9K | $60.7K |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | -$7.0K | $14.6K | -$28.1K | $3.0K |
| Operating Income Loss | -$24.1M | $793.7K | $1.2M | $197.0K |
| Operating Expenses | $26.5M | $1.4M | $967.6K | $1.2M |
| Nonoperating Income Expense | $64.8K | -$293.00 | $1.0K | -$7.0K |
| Net Income Loss | -$24.4M | $478.6K | $852.0K | $191.3K |
| Income Tax Expense Benefit | $280.6K | $314.9K | $329.5K | -$1.3K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$24.1M | $793.4K | $1.2M | $190.0K |
| Gross Profit | $2.4M | $2.2M | $2.1M | $1.4M |
| General And Administrative Expense | $25.5M | $814.9K | $485.0K | $707.5K |
| Deferred Income Tax Expense Benefit | -$26.7K | -$21.5K | -$33.7K | -$1.3K |
| Cost Of Revenue | $142.5K | $195.3K | $311.0K | $509.2K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$7.0K | $14.6K | -$28.1K | $3.0K |
| Comprehensive Income Net Of Tax | -$24.4M | $493.1K | $823.9K | $194.3K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $4.0M | $1.5M | $1.0M | $150.3K | -$578.2K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.8M | $547.5K | $1.0M | $574.7K | $72.7K |
| Noncash Lease Expenses | $37.4K | $30.4K | $45.9K | $32.9K | |
| Inventory Write Down | $1.4K | $16.0K | $1.2K | $8.7K | |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $144.9K | $65.9K | $52.7K | $26.0K | |
| Other Assets Noncurrent | $105.8K | $56.7K | $9.9K | ||
| Taxes Payable Current | $1.4M | $1.0M | $579.9K | ||
| Retained Earnings Accumulated Deficit | -$24.2M | $271.8K | -$105.2K | ||
| Property Plant And Equipment Net | $158.0K | $104.0K | $38.6K | ||
| Other Receivables And Other Current Assets | $352.6K | $1.1M | $366.8K | ||
| Operating Lease Right Of Use Asset | $180.2K | $70.7K | $31.9K | ||
| Operating Lease Liability Noncurrent | $75.9K | $52.7K | $9.5K | ||
| Operating Lease Liability Current | $104.3K | $17.6K | $22.0K | ||
| Notes And Loans Receivable Net Current | $1.0M | $746.0K | $300.3K | ||
| Liabilities Noncurrent | $75.9K | $52.7K | $9.5K | ||
| Liabilities Current | $1.9M | $1.5M | $1.2M | ||
| Liabilities And Stockholders Equity | $6.0M | $3.1M | $2.3M | ||
| Liabilities | $2.0M | $1.6M | $1.3M | ||
| Inventory Net | $75.2K | $71.5K | $95.9K | ||
| Intangible Assets Net Excluding Goodwill | $6.6K | $7.6K | $8.4K | ||
| Contract With Customer Liability Current | $194.8K | $325.9K | $250.5K | ||
| Common Stock Value | $500.00 | $500.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $3.2M | -$505.1K | $473.0K | $564.3K | |
| Assets Noncurrent | $450.7K | $239.0K | $88.7K | ||
| Assets Current | $5.5M | $2.8M | $2.2M | ||
| Assets | $6.0M | $3.1M | $2.3M | ||
| Additional Paid In Capital Common Stock | $28.0M | $1.2M | $1.2M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$66.4K | -$59.4K | -$73.9K | ||
| Accounts Receivable Net Current | $255.8K | $330.9K | $361.7K | ||
| Accounts Payable Current | $12.0K | $24.1K | $197.2K | ||
| Accounts Payable And Other Accrued Liabilities Current | $188.3K | $155.9K | $125.2K | ||
| Repayments Of Related Party Debt | $73.3K | $776.1K | $257.6K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Proceeds From Related Party Debt | $6.9K | $4.2K | $60.9K | $393.1K |
| Payments To Acquire Productive Assets | $88.8K | $85.6K | $22.7K | $11.9K |
| Payments To Acquire Loans Receivable | $1.1M | $1.2M | $311.1K | $1.5M |
| Net Cash Provided By Used In Operating Activities | $85.9K | $960.5K | $126.5K | $1.4M |
| Net Cash Provided By Used In Investing Activities | -$572.9K | -$508.1K | $1.0M | -$1.5M |
| Net Cash Provided By Used In Financing Activities | $3.7M | -$957.4K | -$676.9K | $669.7K |
| Increase Decrease In Prepaid Supplies | -$9.7K | -$76.9K | -$9.0K | $6.2K |
| Increase Decrease In Other Receivables | $324.3K | $36.9K | $265.8K | $56.1K |
| Increase Decrease In Other Noncurrent Assets | $20.3K | -$9.6K | -$178.0K | $187.5K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$1.8K | $27.5K | $35.3K | $39.4K |
| Increase Decrease In Operating Lease Liability | -$37.0K | -$30.4K | -$44.7K | -$33.0K |
| Increase Decrease In Inventories | $17.5K | -$10.5K | $2.8K | -$193.6K |
| Increase Decrease In Contract With Customer Liability | -$129.4K | $68.7K | -$989.1K | $1.2M |
| Increase Decrease In Accrued Income Taxes Payable | $369.2K | $403.4K | $437.3K | $82.1K |
| Increase Decrease In Accounts Receivable | -$72.0K | $98.7K | $337.7K | $87.8K |
| Increase Decrease In Accounts Payable | -$11.9K | -$176.1K | $69.4K | $56.8K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$8.4K | $18.9K | -$14.1K | -$62.3K |
| Proceeds From Collection Of Longterm Loans To Related Parties | $14.1K | $31.5K | $15.6K | $62.8K |
| Proceeds From Collection Of Loans Receivable | $605.0K | $810.7K | $1.4M | |
| Proceeds From Contributed Capital | $500.00 | $38.3K | $534.1K | |
| Payments To Fund Longterm Loans To Related Parties | $28.3K | $20.0K | $77.1K | |
| Payments Of Stock Issuance Costs | $549.1K | $888.8K | ||
| Share Based Compensation | $24.1M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 588.9K | 500.0K | 500.0K | 25.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 588.9K | 500.0K | 500.0K | 25.0M |
| Earnings Per Share Diluted | $-41.38 | $0.96 | $1.70 | $0.01 |
| Earnings Per Share Basic | $-41.38 | $0.96 | $1.70 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Provision For Doubtful Accounts | $184.2K | $179.9K | $152.1K | $6.4K |
| Investment Income Interest | $6.1K | $783.00 | $1.6K | $263.00 |
| Depreciation And Amortization | $109.4K | $22.7K | $20.1K | $30.5K |
| Supplies | $9.4K | $19.2K | $598.00 | |
| Statutory Accounting Practices Statutory Capital And Surplus Balance | $217.3K | $132.0K | $30.4K | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $500.00 | $38.3K | $534.2K |
Most recent annual filing with the SEC: March 2, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.